NCT02578797 2023-11-09A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc StudyAragon Pharmaceuticals, Inc.Phase 1 Completed45 enrolled
NCT00749502 2013-07-25A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)Tesaro, Inc.Phase 1 Completed113 enrolled